LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 48.65 | 84.90 | 179 | 5328 | 0.0336 | 0.1330 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 48.65 | 84.90 | 2643 | 5328 | 0.4960 | 0.7784 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 50.36 | 84.90 | 2421 | 5651 | 0.4284 | 0.7388 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 50.36 | 84.90 | 2444 | 5651 | 0.4325 | 0.7415 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 50.36 | 84.90 | 223 | 5651 | 0.0395 | 0.1729 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 50.36 | 84.90 | 2854 | 5651 | 0.5050 | 0.7867 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 52.06 | 84.90 | 2535 | 5990 | 0.4232 | 0.7386 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 52.06 | 84.90 | 2556 | 5990 | 0.4267 | 0.7410 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 52.06 | 84.90 | 244 | 5990 | 0.0407 | 0.1876 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 52.06 | 84.90 | 3060 | 5990 | 0.5108 | 0.7927 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 53.77 | 84.90 | 2686 | 6252 | 0.4296 | 0.7453 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 53.77 | 84.90 | 2704 | 6252 | 0.4325 | 0.7472 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 53.77 | 84.90 | 282 | 6252 | 0.0451 | 0.2135 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 53.77 | 84.90 | 3266 | 6252 | 0.5223 | 0.8012 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 55.48 | 84.90 | 2853 | 6567 | 0.4344 | 0.7511 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 55.48 | 84.90 | 2876 | 6567 | 0.4379 | 0.7533 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 55.48 | 84.90 | 310 | 6567 | 0.0472 | 0.2293 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 55.48 | 84.90 | 3509 | 6567 | 0.5343 | 0.8098 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 57.18 | 84.90 | 2983 | 6963 | 0.4284 | 0.7503 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 57.18 | 84.90 | 3007 | 6963 | 0.4318 | 0.7526 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 57.18 | 84.90 | 353 | 6963 | 0.0507 | 0.2512 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 57.18 | 84.90 | 3703 | 6963 | 0.5318 | 0.8109 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 58.88 | 84.90 | 3140 | 7291 | 0.4306 | 0.7542 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 58.88 | 84.90 | 3157 | 7291 | 0.4329 | 0.7557 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 58.88 | 84.90 | 394 | 7291 | 0.0540 | 0.2699 | MN20160318_Q02 | H18 |